Metastatic Gastric Adenocarcinoma Recruiting Phase 1 Trials for Sargramostim (DB00020)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05269381Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsTreatment